BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260610T080000
DTEND;TZID=Europe/Stockholm:20260612T170000
DTSTAMP:20261007T042508
CREATED:20260424T124413Z
LAST-MODIFIED:20260522T121714Z
UID:36953-1781078400-1781283600@senzagen.com
SUMMARY:2026 AFI Symposium
DESCRIPTION:Meet SenzaGen group companies VitroScreen and ToxHub at the 65th AFI Symposium\, June 10-12\, at the Palacongressi in Rimini. \nMeet SenzaGen Group at booth No. 5\nAt the event\, VitroScreen and ToxHub will showcase how our combined scientific capabilities support pharma and medical device development through non-animal safety and efficacy testing approaches\, and regulatory toxicology and pharmacology consultancy. \nPosters: Film-forming effect\, biorevitalizing activity of hyaluronic acid–based devices\nVitroScreen will present new preclinical data using advanced human-relevant models for non-animal efficacy testing of substance-based medical devices\, including the spheroid-based platform VitroScreenORA: \n🎫 Assessment of the film-forming effect of substance-based medical devices on reconstructed human epithelia in vitro \n🎫 Preclinical evaluation of the biorevitalizing activity of hyaluronic acid–based medical devices using an innovative aged human dermal spheroid platform \nToxHub contributes with expertise in regulatory toxicology and risk assessment\, with a special focus on impurity qualification: \n🎫 The qualification for non-mutagenic impurities for high potent APIs
URL:https://senzagen.com/event/2026-afi-symposium/
LOCATION:Rimini\, Italy
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/04/AFI-banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260629
DTEND;VALUE=DATE:20260703
DTSTAMP:20261007T042508
CREATED:20260123T090400Z
LAST-MODIFIED:20260630T092524Z
UID:36525-1782691200-1783036799@senzagen.com
SUMMARY:ESTIV 2026
DESCRIPTION:Maastricht\, the Netherlands\n“Ensuring Safety\, Advancing Science: Bridging to the Future with NAMs” \nPosters\nTuesday\, 30 June \nP23: #272 – “Adapting RNA-seq as an alternative acquisition platform for gene expression quantification in the GARDskin assay” \np71: #269 – “In vitro sensitization assessment of medical device extracts: Prevalidation results of GARDskin Medical Device for potential inclusion in ISO 10993-10”
URL:https://senzagen.com/event/estiv-2026/
LOCATION:Maastricht
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/01/2026-ESTIV-eventpage-banner-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260913
DTEND;VALUE=DATE:20260917
DTSTAMP:20261007T042508
CREATED:20260123T082112Z
LAST-MODIFIED:20260827T083829Z
UID:36512-1789257600-1789603199@senzagen.com
SUMMARY:Eurotox 2026
DESCRIPTION:Come meet us at Booth #58 and join our scientific session and poster presentations\, showcasing the latest GARD® data and case studies generated in collaboration with industry leaders. \n \nSenzaGen-hosted session\nHall M | Tuesday\, 15 September | 12:15 – 13:15\nAdvancing NAMs for skin and respiratory sensitization testing: Industry case studies on Essential Oils\, Natural Extracts\, and Difficult-to-test samples\n \nFeaturing guest speakers from ExxonMobil\, dōTERRA\, and the Research Institute for Fragrance Materials (RIFM)\, this session will highlight how GARD® data support Quantitative Risk Assessment and regulatory testing under OECD DA 497. \n  \nAgenda\n1. Introduction to the GARD® technology for skin and respiratory sensitization testing \nAndy Forreryd\, PhD |  Scientific Liaison\, SenzaGen \n2. Application of the “2 out of 3” Defined Approach (OECD 497) to assess skin sensitization potential of Difficult-to-test substances \nMegan Solan\, PhD | Toxicologist\, ExxonMobil Biomedical Sciences \n3. A comparative analysis of test methods for predicting dermal sensitization potency in Essential Oils \nJoe Dawson | Product Safety Manager\, dōTERRA \n4. Case study of GARD®skin Dose-Response on Natural Extracts and Quantitative Risk Assessment \nIsabelle Lee\, PhD | Manager of Human Health Science and Strategy\, RIFM \nPoster presentations\nSpotlight on Natural Complex Substances and In silico methods for Enviromental Risk Assessment\n P21-22 #1612 | Joint poster presented by ICCS \nRoom 0.11-0.12 | Tue\, 15 September | 09:30 \nAdaptation of the Next‑Generation Risk Assessment Framework for Skin Sensitization for the use of Natural Complex Substances  \n P18-74 #1159 | Poster presented by ToxHub \nRoom 0.11-0.12 | Mon\, 14 September | 09:30 \nReliability of QSAR-Based LogKow predictions in pharmaceutical Environmental Risk Assessment \nMore at our booth\nRegulatory expertise now complemented by in silico toxicology services\nMeet ToxHub\, our consultancy unit specializing in toxicological risk assessment and regulatory strategy consulting\, with expertise across medical devices\, pharmaceuticals\, cosmetics and chemicals. \nToxHub has recently lauched a new in silico toxicology service area\, providing QSAR-based hazard profiling to support both human health and environmental endpoints. \nDiscover how ToxHub can support your needs
URL:https://senzagen.com/event/eurotox-2026/
LOCATION:Vienna\, Austria
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/01/Lime-Evite_2026-Eurotox-Lime-banner_v1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261006T160000
DTEND;TZID=Europe/Stockholm:20261006T170000
DTSTAMP:20261007T042508
CREATED:20260923T132327Z
LAST-MODIFIED:20260924T074811Z
UID:37439-1791302400-1791306000@senzagen.com
SUMMARY:Webinar: In vitro skin sensitization potency assessment - Part 3
DESCRIPTION:Expert roundtable: How do we assess skin sensitization potency of Complex Mixtures?\nIndustry and scientific perspectives on current challenges\, emerging approaches and new data on Essential Oils\nHow can reliable skin sensitization potency estimates be generated for Natural Complex Substances and other complex mixtures using New Approach Methodologies (NAMs)? \nIn this webinar\, Joe Dawson\, Product Safety Manager at dōTERRA\, will present key findings from a recently published study comparing different approaches to quantitative potency assessment of Essential Oils. \nThe presentation will be followed by a live expert roundtable featuring speakers from dōTERRA\, the Research Institute for Fragrance Materials (RIFM)\, and SenzaGen. Together\, the panel will explore current challenges\, practical applications\, and future directions for skin sensitization potency assessment of complex mixtures. \nFor those who missed our EUROTOX session\, this webinar also offers an opportunity to hear the scientific rationale and key findings behind the newly published study. \nThe webinar presentations will last around 25 minutes\, followed by a 35-minutes live Q&A and expert roundtable discussion. If you cannot attend the live event\, register now to get access to the recording 🎧. \nWhat is your biggest challenge in skin sensitization potency assessment? Submit your question in the registration form and help shape the expert roundtable discussion. Selected questions and topics will be featured during the live session. \n  \n \nKey takeaways\n\nInsights from a newly published study comparing GARD® skin Dose-Response\, component-based prediction model\, and historical LLNA data for Essential Oils.\nCurrent challenges and opportunities in quantitative skin sensitization potency assessment of Complex Mixtures.\nExpert perspectives on practical applications\, challenges\, and future directions in NAM-based potency assessment.\n\nSpeakers\n \nAndy Forreryd\, PhD\nScientific Liaison Manager @ SenzaGen \n\nCo-developer of the GARD®skin assay (OECD TG 442E).\nMember of the ISO/TC 194/WG 8 on irritation and sensitization.\nMember of OECD expert group on respiratory sensitization.\n\n\nIntroduction to skin sensitization potency assessment and the single assay-based method GARD® skin Dose-Response. \n\n  \n \nJoe Dawson\nProduct Safety Manager @ dōTERRA\n \n\n12 years of experience as a research scientist in the food and cosmetics industries\nExpertise in product safety and scientific evaluation of consumer products\nB.Sc. in Molecular Biology\, University of Utah\, M.S. in Biomedical Informatics at the University of Utah School of Medicine (ongoing).\n\nA comparative analysis of test methods for predicting dermal sensitization potency in Essential Oils. \n  \n \nIsabelle Lee\, PhD\nManager of Human Health Science & Strategy @ RIFM\n \n\nLeads human health science and strategy\, advancing NAMs for ingredient safety.\nHead of skin sensitization team\, overseeing safety assessments and research programs.\nExpert in consumer product ingredient evaluation with a PhD in Pharmacology (UPenn).\n\n 
URL:https://senzagen.com/event/2026-webinar-in-vitro-skin-sensitization-potency-assessment-part-3/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2025/01/Lime-UNIVERSAL-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20261007T042508
CREATED:20260916T104449Z
LAST-MODIFIED:20260916T104526Z
UID:37458-1791849600-1792022399@senzagen.com
SUMMARY:Biocompatibility Insights 2026
DESCRIPTION:Biocompatibility Insights 2026\n Copenhagen\, Denmark\nMore information coming soon.  \n \n 
URL:https://senzagen.com/event/biocompatibility-insights-2026/
LOCATION:Copenhagen\, Denmark
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2026/09/2026-Biocompatibility-insights-event-page-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261115
DTEND;VALUE=DATE:20261119
DTSTAMP:20261007T042508
CREATED:20260911T135953Z
LAST-MODIFIED:20260916T103328Z
UID:37420-1794700800-1795046399@senzagen.com
SUMMARY:ACT 2026
DESCRIPTION:American College of Toxicology (ACT) 47th Annual Meeting\n San Antonio\, USA\nCome meet us at Booth #718 and join our scientific session and poster presentations\, showcasing the latest GARD® data and case studies generated in collaboration with industry leaders.  \n \nPoster\nMonday\, 16 November\, 5:00 pm -6:30 pm \n#2444913 – “Assessing skin sensitization potency and thresholds in Essential Oils: A comparative study using human data\, LLNA\, and GARD® skin Dose-Response” \n 
URL:https://senzagen.com/event/act2026/
LOCATION:San Antonio\, TX\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/09/ACT-am26-banner-event-page.png
END:VEVENT
END:VCALENDAR